Evaluation of Safety and Immunogenicity of Combined Immunization of PPV23 and IIV4

Conditions:   Influenza, Human;   Pneumonia, Pneumococcal Interventions:   Biological: IIV4 and PPV23;   Biological: IIV4;   Biological: PPV23 Sponsors:   China National Biotec Group Company Limited;   Fujian Provincial Center for Disease Control and Prevention;   Chengdu Institute of Biological Products Co.,Ltd.;   Changchun Institute of Biological Products Co., Ltd.;   National Institutes for Food and Drug Control, China;   Guizho u Center for Disease Control and Prevention;   Hunan Provincial Center for Disease Control and Prevention;   Peking University Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials